Cargando…
Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland
Autores principales: | Ahava, Maarit J., Jarva, Hanna, Jääskeläinen, Anne J., Lappalainen, Maija, Vapalahti, Olli, Kurkela, Satu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049924/ https://www.ncbi.nlm.nih.gov/pubmed/35484359 http://dx.doi.org/10.1007/s10096-022-04448-x |
Ejemplares similares
-
SARS-CoV-2 sample-to-answer nucleic acid testing in a tertiary care emergency department: evaluation and utility
por: Jokela, Pia, et al.
Publicado: (2020) -
Introduction and Rapid Spread of SARS-CoV-2 Omicron Variant and Dynamics of BA.1 and BA.1.1 Sublineages, Finland, December 2021
por: Vauhkonen, Hanna, et al.
Publicado: (2022) -
Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infection
por: Ahava, M.J., et al.
Publicado: (2022) -
The phylodynamics of SARS-CoV-2 during 2020 in Finland
por: Truong Nguyen, Phuoc, et al.
Publicado: (2022) -
Real-life clinical sensitivity of SARS-CoV-2 RT-PCR test in symptomatic patients
por: Kortela, Elisa, et al.
Publicado: (2021)